Singapore, April 29 -- Thermo Fisher Scientific has announced the opening of its flagship US Bioprocess Design Center (BDC) at the company's Plainville, Mass., site, expanding the facility to support customers in developing and scaling biologics.

The new centre brings together advanced bioproduction capabilities and hands-on collaboration to help customers accelerate process development and bring transformative therapies to patients faster. The facility demonstrates Thermo Fisher's continued commitment to empowering customers as a trusted innovation partner.

The BDC features 4,000 square feet of laboratory and training space to support customers in developing biologics, including vaccines and cell and gene therapies. Customers will expe...